Nicotinuric acid
CAS No. 583-08-4
Nicotinuric acid ( —— )
Catalog No. M20058 CAS No. 583-08-4
Nicotinuric acid is an acyl glycine which is normally minor metabolites of fatty acids. Acyl glycines are produced through the action of glycine N-acyltransferase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 30 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNicotinuric acid
-
NoteResearch use only not for human use.
-
Brief DescriptionNicotinuric acid is an acyl glycine which is normally minor metabolites of fatty acids. Acyl glycines are produced through the action of glycine N-acyltransferase.
-
DescriptionNicotinuric acid is an acyl glycine which is normally minor metabolites of fatty acids. Acyl glycines are produced through the action of glycine N-acyltransferase.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number583-08-4
-
Formula Weight180.16
-
Molecular FormulaC8H8N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESOC(=O)CNC(=O)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Figge HL et al. Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J Clin Pharmacol. 1988 Dec;28(12):1136-40.
molnova catalog
related products
-
Lapathoside A
Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
Etebenecid
Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
-
PF-1355
PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.